Presence of more activating KIR genes is associated with Hashimoto's thyroiditis

Endocrine

Volumn 46, Issue 3, 2014, Pages 519-525

  Ashouri, Elham ^a   Dabbaghmanesh, Mohammad Hossein ^a   Ranjbar Omrani, Gholamhossein ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gene content profiles; Hashimoto's thyroiditis; KIR; PCR SSP

Indexed keywords

AUTOANTIBODY; DNA; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; AUTOANTIGEN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE; GENE FREQUENCY; HASHIMOTO DISEASE; HUMAN; KIR GENE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PATHOGENESIS; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; ZYGOSITY; ADULT; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; AUTOANTIGENS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HASHIMOTO DISEASE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, KIR; YOUNG ADULT;

EID: 84904543536     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0080-2     Document Type: Article

References (49)

1. E. Vivier, D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, L.L. Lanier, W.M. Yokoyama, S. Ugolini, Innate or adaptive immunity? The example of natural killer cells. Science 331(6013), 44-49 (2011). doi:10.1126/science. 1198687
2. C. Vilches, P. Parham, KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20, 217-251 (2002)
3. L.L. Lanier, NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005). doi:10.1146/annurev.immunol.23.021704.115526
4. R. Rajalingam, Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses. Iran. J. Immunol. 4(2), 61-78 (2007)
5. M.J. Wilson, M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, J. Trowsdale, Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 97(9), 4778-4783 (2000)
6. C.C. Winter, E.O. Long, A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J. Immunol. 158(9), 4026-4028 (1997)
7. N. Wagtmann, R. Biassoni, C. Cantoni, S. Verdiani, M.S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, E.O. Long, Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 2(5), 439-449 (1995)
8. J.E. Gumperz, V. Litwin, J.H. Phillips, L.L. Lanier, P. Parham, The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181(3), 1133-1144 (1995)
9. C. Dohring, D. Scheidegger, J. Samaridis, M. Cella, M. Colonna, A human killer inhibitory receptor specific for HLA-A1,2. J. Immunol. 156(9), 3098-3101 (1996)
10. F. Vely, M. Peyrat, C. Couedel, J. Morcet, F. Halary, F. Davodeau, F. Romagne, E. Scotet, X. Saulquin, E. Houssaint, N. Schleinitz, A. Moretta, E. Vivier, M. Bonneville, Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 166(4), 2487-2494 (2001)
11. J. Trowsdale, R. Barten, A. Haude, C.A. Stewart, S. Beck, M.J. Wilson, The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181, 20-38 (2001)
12. H.G. Shilling, L.A. Guethlein, N.W. Cheng, C.M. Gardiner, R. Rodriguez, D. Tyan, P. Parham, Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J. Immunol. 168(5), 2307-2315 (2002)
13. K.C. Hsu, S. Chida, D.E. Geraghty, B. Dupont, The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol. Rev. 190, 40-52 (2002)
14. A.M. Martin, J.K. Kulski, S. Gaudieri, C.S. Witt, E.M. Freitas, J. Trowsdale, F.T. Christiansen, Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B. Gene 335, 121-131 (2004)
15. H.G. Shilling, N. Young, L.A. Guethlein, N.W. Cheng, C.M. Gardiner, D. Tyan, P. Parham, Genetic control of human NK cell repertoire. J. Immunol. 169(1), 239-247 (2002)
16. D. Middleton, M. Curran, L. Maxwell, Natural killer cells and their receptors. Transpl. Immunol. 10(2-3), 147-164 (2002)
17. K.L. McQueen, P. Parham, Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14(5), 615-621 (2002). S0952791502003801 [pii]
18. A.R. van der Slik, B.P. Koeleman, W. Verduijn, G.J. Bruining, B.O. Roep, M.J. Giphart, KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52(10), 2639-2642 (2003)
19. T. Momot, S. Koch, N. Hunzelmann, T. Krieg, K. Ulbricht, R.E. Schmidt, T. Witte, Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum. 50(5), 1561-1565 (2004)
20. F. Pellett, F. Siannis, I. Vukin, P. Lee, M.B. Urowitz, D.D. Gladman, KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens 69(Suppl 1), 106-108 (2007). doi:10.1111/j.1399- 0039.2006.762-6.x
21. S. Kulkarni, M.P. Martin, M. Carrington, The Yin and Yang of HLA and KIR in human disease. Semin. Immunol. 20(6), 343-352 (2008)
22. R. Rajalingam, Human diversity of killer cell immunoglobulin-like receptors and disease. Korean J. Hematol. 46(4), 216-228 (2011). doi:10.5045/kjh.2011.46.4.216
23. M.P. Vanderpump, W.M. Tunbridge, Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 12(10), 839-847 (2002). doi:10.1089/105072502761016458
24. D.S. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2), 252-265 (2012). doi:10.1007/s12020-012-9703-2
25. Y. Ban, T.F. Davies, D.A. Greenberg, A. Kissin, B. Marder, B. Murphy, E.S. Concepcion, R.B. Villanueva, G. Barbesino, V. Ling, Y. Tomer, Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 4(8), 586-593 (2003). doi:10.1038/sj.gene.6364018
26. S. Alfadhli, Q. Almutawa, J.M. Abbas, S.A. Doi, Association of Hashimoto's thyroiditis with cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and inducible co-stimulator (ICOS) genes in a Kuwaiti population. Endocrine 43(3), 666-677 (2013). doi:10.1007/s12020-012-9823-8
27. A.W. Michels, G.S. Eisenbarth, Immunologic endocrine disorders. J. Allergy Clin. Immunol. 125(2 Suppl 2), S226-S237 (2010). doi:10.1016/j.jaci. 2009.09.053
28. S.B. Solerte, S. Precerutti, C. Gazzaruso, E. Locatelli, M. Zamboni, N. Schifino, R. Bonacasa, M. Rondanelli, D. Taccani, E. Ferrari, M. Fioravanti, Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur. J. Endocrinol. 152(5), 703-712 (2005). doi:10.1530/eje.1.01906
29. C.M. Dayan, G.H. Daniels, Chronic autoimmune thyroiditis. N. Engl. J.Med. 335(2), 99-107 (1996). doi:10.1056/NEJM199607113350206
30. S. Melmed, K.S. Polonsky, P. Reed, M.L. Kronenberg, M.H. Kronenberg, Williams Textbook of Endocrinology, 12th edn. (Saunders Elsevier Health Sciences, Philadelphia, 2012)
31. Z. Du, D.W. Gjertson, E.F. Reed, R. Rajalingam, Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 59(1), 1-15 (2007)
32. E. Ashouri, A. Ghaderi, E.F. Reed, R. Rajalingam, A novel duplex SSP-PCR typing method for KIR gene profiling. Tissue Antigens 74(1), 62-67 (2009). doi:10.1111/j.1399-0039.2009.01259.x
33. E. Ashouri, M.H. Dabbaghmanesh, S. Rowhanirad, M. Bakhshayeshkaram, Ranjbar Omrani, G., Ghaderi, A.: Activating KIR2DS5 receptor is a risk for thyroid cancer. Hum. Immunol. 73(10), 1017-1022 (2012). doi:10.1016/j.humimm. 2012.07.325
34. F.F. Gonzalez-Galarza, S. Christmas, D. Middleton, A.R. Jones, Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 39, D913-919 (2011). doi:10.1093/nar/gkq1128
35. E. Ashouri, S. Farjadian, E.F. Reed, A. Ghaderi, R. Rajalingam, KIR gene content diversity in four Iranian populations. Immunogenetics 61(7), 483-492 (2009). doi:10.1007/s00251-009-0378-7
36. D.G. Augusto, S.C. Lobo-Alves, M.F. Melo, N.F. Pereira, M.L. Petzl-Erler, Activating KIR and HLA Bw4 ligands are associated to decreased susceptibility to pemphigus foliaceus, an autoimmune blistering skin disease. PLoS ONE 7(7), e39991 (2012). doi:10.1371/journal.pone.0039991
37. Z. HaiQing, Z. JiaJun, Z. YueRan, G. Ling, G. QingBo, L. Lin, J. YuLian, Genotypes of killer cell immunoglobulin-like receptors in Hashimoto's thyroiditis patients. Journal of Shandong University (Health Sciences) 47(8), 1-4 (2009)
38. A.R. van der Slik, B.Z. Alizadeh, B.P. Koeleman, B.O. Roep, M.J. Giphart, Modelling KIR-HLA genotype disparities in type 1 diabetes. Tissue Antigens 69(Suppl 1), 101-105 (2007). doi:10.1111/j.1399-0039.2006.762-5.x
39. F.D. Shi, H.B. Wang, H. Li, S. Hong, M. Taniguchi, H. Link, L. Van Kaer, H.G. Ljunggren, Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1(3), 245-251 (2000). doi:10.1038/79792
40. L.H. Duntas, Environmental factors and autoimmune thyroiditis. Nat. Clin. Pract. Endocrinol. Metab. 4 (8), 454-460 (2008). doi:10.1038/ncpendmet0896
41. M.R. Snyder, T. Nakajima, P.J. Leibson, C.M. Weyand, J.J. Goronzy, Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J. Immunol. 173(6), 3725-3731 (2004)
42. K.J. Warrington, S. Takemura, J.J. Goronzy, C.M. Weyand, CD4 +, CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum. 44(1), 13-20 (2001)
43. D. Basu, Y. Liu, A. Wu, S. Yarlagadda, G.J. Gorelik, M.J. Kaplan, A. Hewagama, R.C. Hinderer, F.M. Strickland, B.C. Richardson, Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J. Immunol. 183(5), 3481-3487 (2009)
44. S. Kulkarni, R.M. Single, M.P. Martin, R. Rajalingam, R. Badwe, N. Joshi, M. Carrington, Comparison of the rapidly evolving KIR locus in Parsis and natives of India. Immunogenetics 60(3-4), 121-129 (2008). doi:10.1007/s00251- 008-0279-1
45. R. Rajalingam, Z. Du, A. Meenagh, L. Luo, V.J. Kavitha, R. Pavithra-Arulvani, A. Vidhyalakshmi, S.K. Sharma, I. Balazs, E.F. Reed, R.M. Pitchappan, D. Middleton, Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations. Immunogenetics 60(5), 207-217 (2008). doi:10.1007/s00251-008-0286-2
46. G. Contreras, C. Alaez, A. Murguia, D. Garcia, H. Flores, C. Gorodezky, Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos. Tissue Antigens 69(Suppl 1), 125-129 (2007). doi:10.1111/j.1399-0039. 2006.76212.x
47. L.M. Hurtado-Lopez, E. Basurto-Kuba, E.R. Montes de Oca-Duran, A. Pulido-Cejudo, R. Vazquez-Ortega, C. Athie-Gutierrez, Prevalence of thyroid nodules in the Valley of Mexico. Cir. Cir. 79(2), 114-117 (2011)
48. A.G. Unnikrishnan, U.V. Menon, Thyroid disorders in India: an epidemiological perspective. Indian journal of endocrinology and metabolism 15(Suppl 2), S78-S81 (2011). doi:10.4103/2230-8210.83329
49. R.K. Marwaha, N. Tandon, A.K. Karak, N. Gupta, K. Verma, N. Kochupillai, Hashimoto's thyroiditis: countrywide screening of goitrous healthy young girls in postiodization phase in India. J. Clin. Endocrinol. Metab. 85(10), 3798-3802 (2000)